AGIOLAX

This brand name is authorized in Brazil, Finland, France, Hong Kong SAR China, Ireland, Israel, Netherlands, Poland, Spain.

Active ingredients

The drug AGIOLAX contains one active pharmaceutical ingredient (API):

1	Sennosides UNII F887D1637W - SENNOSIDE B
	The sugar moiety of the sennosides is removed by bacteria in the large intestine releasing the active anthrone fraction. This stimulates peristalsis via the submucosal and myenteric nerve plexuses.
	Read more about Sennosides

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A06AB56	Senna glycosides, combinations	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AB Contact laxatives
Discover more medicines within A06AB56
A06AC51	Ispaghula, combinations	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AC Bulk producers
Discover more medicines within A06AC51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	541519120017117, 541519120017217
ES	Centro de información online de medicamentos de la AEMPS	56285
FI	Lääkealan turvallisuus- ja kehittämiskeskus	182529, 395829
FR	Base de données publique des médicaments	66768488
HK	Department of Health Drug Office	57858
IL	מִשְׂרַד הַבְּרִיאוּת	2920
PL	Rejestru Produktów Leczniczych	100003283